Anuh Pharma Limited (ANUHPHR) Stock Statistics & Valuation Metrics

Anuh Pharma Limited has a market cap or net worth of ₹7.88B. The enterprise value is ₹8.27B.

Anuh Pharma Limited has 100,224,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Anuh Pharma Limited’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Anuh Pharma Limited is 20.3. Anuh Pharma Limited’s PEG ratio is 0.00.

In the last 12 months, Anuh Pharma Limited had revenue of 6.62B and earned 473.52M in profits. Earnings per share was 4.72.

In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.

Anuh Pharma Limited pays an annual dividend of ₹1.5, resulting in a dividend yield of 1.93%

Anuh Pharma Limited upcoming earnings date is Feb 6, 2026, TBA (Confirmed).

Anuh Pharma Limited as a current ratio of ―, with Debt / Equity ratio of ―

In the past 12 months, Anuh Pharma Limited has paid 136.53M in taxes.

Anuh Pharma Limited EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Anuh Pharma Limited has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.

Gross margin is ―, with operating margin of ―, and net profit margin of ―.

The average price target for Anuh Pharma Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―